4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-24-014594
EVP, Chief Technology Officer sold 2,305 shares at $95.00 ($218,975)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lingamneni Anila · EVP, Chief Technology Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-06 | Sale : show line 1 in the form 10b5-1 | −2,305 | $95.00 | $218,975 | 12,295 | D |
| Open-market sales · 2,305 sh · avg $95.00 · $218,975 | ||||||
Loading xslF345X05/form4.xml…